Anthony S. Stein
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anthony S. Stein as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:10 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03467386 · Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid LeukemiaCity of Hope Medical Center · active not recruiting · Acute Myeloid Leukemia
- Ph1/Ph2NCT01795924 · Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic SyndromeBiosuccess Biotech Co., Ltd. · terminated · Acute Myelogenous Leukemia, Myelodysplastic Syndrome
- Ph1/Ph2NCT00576979 · Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaCity of Hope Medical Center · completed · Leukemia · study chair
- Ph2NCT00534469 · Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep RCity of Hope Medical Center · completed · Leukemia · study chair
- Ph2NCT00534430 · Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic CancerCity of Hope Medical Center · completed · Leukemia, Myelodysplastic Syndromes · study chair
- Ph2NCT00528398 · Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid LeukemiaCity of Hope Medical Center · completed · Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Image-guided irradiation safely intensifies HSCT regimen for refractory leukemiaR01CA195519 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2016 to 2018 · $238,425 awarded in 2018Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Conformal Total Body and Marrow Irradiation for LeukemiaR01CA154491 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Susanta K Hui, JEFFREY Y WONG · fiscal years 2011 to 2024Named on NCT00576979
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2007 to 2026
Most cited trial papers
Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 12:10 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia.Am J Hematol · 2017143 citationsRCR 4.1
- 49 citationsRCR 1.6
- Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemia.Eur J Haematol · 20213 citationsRCR 0.2